Northwest Medical Specialties B

Federal Way, Washington 98003

0 studies enrolling now · 2 studies all time

What they study most

Advanced Unresectable or Metastatic Solid Malignancy, B-cell Lymphoma

Studies at this site

• A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response — Completed
• A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma — Stopped early